These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 29962346)

  • 21. Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia.
    Schmidt W; Schäfer F; Striggow V; Fröhlich K; Striggow F
    Neuroscience; 2012 Dec; 227():313-26. PubMed ID: 23069763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders.
    Kibret BG; Ishiguro H; Horiuchi Y; Onaivi ES
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabinoid receptor 2 selective agonists and Alzheimer's disease: An insight into the therapeutic potentials.
    Magham SV; Thaggikuppe Krishnamurthy P; Shaji N; Mani L; Balasubramanian S
    J Neurosci Res; 2021 Nov; 99(11):2888-2905. PubMed ID: 34486749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocannabinoids in the gastrointestinal tract.
    Lee Y; Jo J; Chung HY; Pothoulakis C; Im E
    Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G655-G666. PubMed ID: 27538961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic potential of cannabinoid receptor ligands: current status.
    Singh J; Budhiraja S
    Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):177-83. PubMed ID: 16810344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Chronic Alcohol Exposure on the Modulation of Ischemia-Induced Glutamate Release via Cannabinoid Receptors in the Dorsal Hippocampus.
    Zheng L; Wu X; Dong X; Ding X; Song C
    Alcohol Clin Exp Res; 2015 Oct; 39(10):1908-16. PubMed ID: 26343919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-Inflammatory Effects of Fatty Acid Amide Hydrolase Inhibition in Monocytes/Macrophages from Alzheimer's Disease Patients.
    Chiurchiù V; Scipioni L; Arosio B; Mari D; Oddi S; Maccarrone M
    Biomolecules; 2021 Mar; 11(4):. PubMed ID: 33810505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review.
    Svízenská I; Dubový P; Sulcová A
    Pharmacol Biochem Behav; 2008 Oct; 90(4):501-11. PubMed ID: 18584858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The endocannabinoidome in neuropsychiatry: Opportunities and potential risks.
    Morris G; Walder K; Kloiber S; Amminger P; Berk M; Bortolasci CC; Maes M; Puri BK; Carvalho AF
    Pharmacol Res; 2021 Aug; 170():105729. PubMed ID: 34119623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging.
    Pascual AC; Gaveglio VL; Giusto NM; Pasquaré SJ
    Exp Gerontol; 2014 Jul; 55():134-42. PubMed ID: 24768821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
    Fride E
    Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Endocannabinoid System in Pediatric Inflammatory and Immune Diseases.
    Argenziano M; Tortora C; Bellini G; Di Paola A; Punzo F; Rossi F
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different expression and function of the endocannabinoid system in human epicardial adipose tissue in relation to heart disease.
    Cappellano G; Uberti F; Caimmi PP; Pietronave S; Mary DA; Dianzani C; Micalizzi E; Melensi M; Boldorini R; Nicosia G; Crosio E; Chiocchetti A; Aina F; Prat M; Dianzani U; Vacca G; Ariatti C; Grossini E
    Can J Cardiol; 2013 Apr; 29(4):499-509. PubMed ID: 22926037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of CB
    Wu J; Hocevar M; Foss JF; Bie B; Naguib M
    Eur J Pharmacol; 2017 Sep; 811():12-20. PubMed ID: 28551012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer's disease mouse model.
    Schmöle AC; Lundt R; Ternes S; Albayram Ö; Ulas T; Schultze JL; Bano D; Nicotera P; Alferink J; Zimmer A
    Neurobiol Aging; 2015 Feb; 36(2):710-9. PubMed ID: 25443294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocannabinoids and Mental Disorders.
    Rubino T; Zamberletti E; Parolaro D
    Handb Exp Pharmacol; 2015; 231():261-83. PubMed ID: 26408164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptor-Dependent and Independent Regulation of Voltage-Gated Ca
    Boczek T; Zylinska L
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex.
    Lee JH; Agacinski G; Williams JH; Wilcock GK; Esiri MM; Francis PT; Wong PT; Chen CP; Lai MK
    Neurochem Int; 2010 Dec; 57(8):985-9. PubMed ID: 21034788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissecting the cannabinergic control of behavior: The where matters.
    Busquets-Garcia A; Desprez T; Metna-Laurent M; Bellocchio L; Marsicano G; Soria-Gomez E
    Bioessays; 2015 Nov; 37(11):1215-25. PubMed ID: 26260530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain.
    Onaivi ES; Ishiguro H; Gong JP; Patel S; Perchuk A; Meozzi PA; Myers L; Mora Z; Tagliaferro P; Gardner E; Brusco A; Akinshola BE; Liu QR; Hope B; Iwasaki S; Arinami T; Teasenfitz L; Uhl GR
    Ann N Y Acad Sci; 2006 Aug; 1074():514-36. PubMed ID: 17105950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.